Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
6
×
celgene
6
×
detroit blog main
detroit top stories
6
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
6
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
johnson & johnson
pfizer
abbvie
clinical trials
fda
genentech
nash
acquisition
aducanumab
astrazeneca
avexis
What
bio
6
×
roundup
drug
news
approved
biogen
disease
fda
liver
nash
race
week
adu
aducanumab
advanced
alnylam’s
alzheimer’s
amyloid
angst
approval
august
bagged
beats
bff
bids
billions
biogen’s
biopharma
biotech
brammer
busy
car
celgene
colleagues
companies
complicated
conference
days
deals
decisions
Language
unset
Current search:
celgene
×
bio
×
" detroit top stories "
×
" bristol-myers squibb "
×
" new york top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More